最新消息
News & Message
:::
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial
Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Metastatic Cholangiocarcinoma: a Phase 1b/2 Study
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
2025/2/4
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
作者群：Xu J, Kato K, Raymond E, Hubner RA, Shu Y, Pan Y, Park SR, Ping L, Jiang Y, Zhang ., Wu X, Yao Y, Shen ., Kojima T, Gotovkin, E, Ishihara R, Wyrwicz L, Van Cutsem E, Jimenez-Fonseca. P, Lin CY (林振源), Wang L, Shi J, Li L, Yoon HH.
期刊：Lancet Oncol
出版年月：2023
圖片來源：Lancet Oncol
連結：https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00108-0/abstract
相關文章
開關
首頁
Facebook
Instagram
體系醫院
中國醫點通